Last updated: 2026-11-14 11:52:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
PAVmed Inc. (PAVM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.62, with a market capitalization of $10.71M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.17 to $28.44. This page covers its latest market performance, valuation, price trends and company information.
$10.71M | |
$1.47 | |
$1.72 | |
$1.28 | |
$1.34 | |
56.20K | |
20.33K | |
-- | |
$28.44 | |
$1.17 | |
-- | |
-- |
PAVmed Inc. (PAVM) last closed at $1.62 as of 2026-11-14 00:43:00, up 14.26% ($0.19) from the previous close of $1.34.
During the latest regular trading session, PAVM traded between $1.28 and $1.72, with a volume of 56.20K shares. The closing price was near the upper end and near the lower end of its 52-week range.
PAVM is up 0.43% as of the last close.
Over the past seven days, PAVmed Inc. (PAVM) moved from $1.55 to $1.62, representing a gain of 4.45% ($0.07).
The stock traded between $1.17 and $1.72 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 22.51 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.6%
PAVM is currently trading at $1.62, placing it 1.6% of the way from its 52-week low of $1.17 to its 52-week high of $28.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 41 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to PAVmed Inc. and PAVM stock.
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.59) by 67.8 percent. This is a 68.33 percent increase over losses of $(0.60) per share from the same
Eligible investors can buy real shares of PAVmed Inc. (PAVM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PAVM, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between PAVM shares and USD.
PAVM Shares to USD
1.00 PAVM shares = 1.619 USD
Calculations are estimates based on the latest available price and are for reference only.
